Decentralized Clinical Trials - Capabilities and Solutions | PPD

How We Help Decentralized Clinical Trials DCT Capabilities and Solutions

Our DCT ecosystem optimizes decentralized clinical trials

The goal of the PPD™ clinical research business of Thermo Fisher Scientific has always been to optimize the patient and site’s experience within a decentralized setting. We leverage years of industry-leading experience along with new capabilities to build a comprehensive collective of solutions for decentralized clinical trials. Tim Rich, Vice President of Digital and Decentralized solutions discusses how our DCT ecosystem enables consultants to precisely apply the right strategies at the right times, benefiting trials, sites, and patients.

Telemedicine

Telemedicine enables patients to stay connected to their clinicians, utilizing convenient digital tools that don’t require frequent site visits. Sites can continue their standard of care, reduce protocol deviations, and collect quality data – all with limited interruption.

Learn how telemedicine benefits sites and patients with our video

See how we’re keeping studies on track with telemedicine options

Direct-to/from-patient models

When patients are unable to visit a site, clinical materials such as samples, supplies and unused investigational medicinal products (IMPs) can be directly shipped or collected from the patient’s home, so study assessments aren’t disrupted, nor are patients’ lives.

See how we’re keeping patients safe with a Direct-to-Patient (DTP) strategy

Remote e-consent

Patients can securely review required study documents and provide a digital signature for consent (or re-consent) remotely from the comfort of their homes, so enrollment timelines stay on track, patients are better informed and compliance is maintained.

Learn how decentralization decreases patient burden with our webinar

Home health care & nursing

We leverage a network of home health care (HHC) nurses in over 40 countries that enable clinical trials to occur off-site in the patient’s home. This includes the preparation and administration of study drugs, conducting clinical assessments, ensuring eDiary compliance and more.

Read about how home health care solutions play a crucial role in enhancing patient engagement

Increase engagement and retention with our patient concierge service

ECOA and EPRO

Electronic clinical outcomes assessments (eCOAs) and electronic patient reported outcomes (ePROs) use digital platforms to enable direct data collection from study stakeholders. The result is less paper documentation and more timely data, with greater consistency from patients.

Learn how ecoa can accelerate clinical research with our video

See how you can integrate digital clinical outcome assessments into your clinical trials

Specialized sites

A decentralized solution to place professional clinical research care in the heart of diverse and underrepresented communities. This service offers community and patient centric engagement strategies, driving faster recruitment combined with convenience for participants that increases retention while providing Principal Investigator (PI) oversight fulfilling the exact same responsibilities of the brick and mortar site PIs.

Learn more about one of the ways that we bring trials directly to patients

Remote monitoring

When clinical research associates (CRAs) cannot physically be at an investigator site or clinic, remote options are available to generate data analytics, enable remote source data verification (rSDV) and perform other monitoring activities.

Watch experts discuss the evolving role of remote monitoring in clinical trials

Open our survey to see what 69% of life science leaders think about remote monitoring as a top strategy

See how we’re driving agile, patient-centric clinical trials

Devices and wearables

Currently, devices and wearable technologies are generating significantly higher levels of clinical data than traditional trial models. These sophisticated tools – smart phone and tablet apps, sports watches, meters and monitors, garments and textile patches – can be more convenient and less intrusive for patients as sites and sponsors seek higher quality insights.

Open our survey to see how 91% of clinical researchers feel about new platforms and technology

Regulatory insights

Our regulatory affairs group provides guidance to support key business decisions around decentralized clinical trials (DCTs). Experts from these teams frequently share informal updates, describing hurdles faced by our industry, related regulatory issues and practical examples of how we manage these issues.

FDA launches digital health center of excellence

Virtual trials gaining traction in the EU

Pandemic speeds adoption of telemedicine in clinical trials

Additional resources

See more ways we can help with your decentralized clinical trials

DCT Network

In an increasingly digital world, decentralized clinical trials (DCTs) have accelerated recruitment, cut trial timelines and removed barriers to reach diverse patient populations. We have developed a DCT certification program to support sites in the DCT space, enabling improved quality and delivery of decentralized trials. Our DCT Network will identify investigators/sites with digital and decentralized capabilities and prepare them through an eLearning program created in collaboration with the Society of Clinical Research Sites (SCRS). Watch the video below to learn more about our DCT Network.

DCT Network for sites

DCT Network for sponsors